3rd Quarter - Report

HEALTHFUTURES, LLC for ASSOCIATION FOR MOLECULAR PATHOLOGY

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Medical/Disease Research/Clinical Labs MED

Issues impacting the legislative and regulatory oversight of genetic testing, reimbursement of diagnostics, comparative effectiveness research, DNA patents, workforce issues, influenza, standards development for diagnostics H.R.1699/S. 1220, Patient Access to Critical Lab Tests Act No bill #,Genomics and Personalized Medicine Act; No bill #, Genomic Research and Accessibility Act

LobbyistCovered position, as disclosed
JENNIFER RACHEL LEIB —
ROBERT WELLS —

Contacted: Health & Human Services, Dept of (HHS); SENATE; HOUSE OF REPRESENTATIVES; Natl Institute of Standards & Technology (NIST)

Bills named: S. 1220 (111th), H.R. 1699 (111th)

Health Issues HCR

HR 3200, America's Affordable Health Choices Act; No bill #, America's Health Futures Act of 2009; Health care reform in general Issues impacting the legislative and regulatory oversight of genetic testing, reimbursement of diagnostics, comparative effectiveness research, DNA patents, workforce issues, influenza H.R. 1699/S. 1220, Patient Access to Critical Lab Tests Act

LobbyistCovered position, as disclosed
JENNIFER RACHEL LEIB —
ROBERT WELLS —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Natl Institute of Standards & Technology (NIST); Health & Human Services, Dept of (HHS)

Bills named: S. 1220 (111th), H.R. 3200 (111th), H.R. 1699 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.